Methicillin-resistant and -susceptible Staphylococcus aureus infections in dogs

Emerging Infectious Diseases

Volumn 16, Issue 1, 2010, Pages 69-75

  Faires, Meredith C ^a   Traverse, Michelle ^b   Tater, Kathy C ^c   Pearl, David L ^a   Weese, J Scott ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c ANGELL ANIMAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CHLORAMPHENICOL; LINCOSAMIDE; NITROIMIDAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG DISEASE; DRUG EXPOSURE; FEMALE; INFECTION RISK; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NONHUMAN; RISK ASSESSMENT; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; VEIN CATHETERIZATION;

ANIMALS; CANADA; CASE-CONTROL STUDIES; COMMUNICABLE DISEASES, EMERGING; DOG DISEASES; DOGS; HUMANS; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PREVALENCE; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; UNITED STATES;

EID: 73949127449     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1601.081758     Document Type: Article

References (27)

1. Walther B, Wieler LH, Friedrich AW, Hanssen AM, Kohn B, Brunnberg L, et al. Methicillin-resistant Staphylococcus aureus (MRSA) isolated from small and exotic animals at a university hospital during routine microbiological examinations. Vet Microbiol. 2008;127:171-8. DOI: 10.1016/j.vetmic.2007.07.018
2. Rich M, Roberts L. MRSA in companion animals. Vet Rec. 2006;159:535-6.
3. Weese JS, Dick H, Willey BM, McGeer A, Kreiswirth BN, Innis B, et al. Suspected transmission of methicillin-resistant Staphylococcus aureus between domestic pets and humans in veterinary clinics and in the household. Vet Microbiol. 2006;115:148-55. DOI: 10.1016/j. vetmic.2006.01.004
4. O'Mahony R, Abbott Y, Leonard FC, Markey BK, Quinn PJ, Pollock PJ, et al. Methicillin-resistant Staphylococcus aureus (MRSA) isolated from animals and veterinary personnel in Ireland. Vet Microbiol. 2005;109:285-96. DOI: 10.1016/j.vetmic.2005.06.003
5. van Duijkeren E, Box ATA, Heck MEOC, Wannet WJB, Fluit AC. Methicillin-resistant staphylococci isolated from animals. Vet Microbiol. 2004;103:91-7. DOI: 10.1016/j.vetmic.2004.07.014
6. Wang JL, Chen SY, Wang JT, Wu GHM, Chiang WC, Hsueh PR, et al. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Clin Infect Dis. 2008;46:799-806. DOI: 10.1086/527389
7. Graffunder EM, Venezia RA. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobial drugs. J Antimicrob Chemother. 2002;49:999-1005. DOI: 10.1093/jac/dkf009
8. Wang FD, Chen YY, Chen TL, Liu CY. Risk factors and mortality in patients with nosocomial Staphylococcus aureus bacteremia. Am J Infect Control. 2008;36:118-22. DOI: 10.1016/j.ajic.2007.02.005
9. Shurland S, Zhan M, Bradham DD, Roghmann MC. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol. 2007;28:273-9. DOI: 10.1086/512627
10. Melzer M, Eykyn SJ, Gransden WR, Chinn S. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Clin Infect Dis. 2003;37:1453-60. DOI: 10.1086/379321
11. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36:53-9. DOI: 10.1086/345476
12. Dancer SJ. The effect of antibiotics on methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 2008;61:246-53. DOI: 10.1093/jac/dkm465
13. Morris DO, Mauldin EA, O'Shea K, Shofer FS, Rankin SC. Clinical, microbiological, and molecular characterization of methicillin-resistant Staphylococcus aureus infections of cats. Am J Vet Res. 2006;67:1421-5. DOI: 10.2460/ajvr.67.8.1421
14. Weese JS, Lefebvre SL. Risk factors for methicillin-resistant Staphylococcus aureus colonization in horses admitted to a veterinary teaching hospital. Can Vet J. 2007;48:921-6.
15. Weese JS, Rousseau J, Willey BM, Archambault M, McGeer A, Low DE. Methicillin-resistant Staphylococcus aureus in horses at a veterinary teaching hospital: frequency, characterization, and association with clinical disease. J Vet Intern Med. 2006;20:182-6. DOI: 10.1892/0891-6640(2006)20[182: MSAIHA]2.0.CO;2
16. StataCorp. Exact logistic regression. In: Stata statistical software, release 10. College Station (TX): StataCorp LP; 2007. p. 423-39.
17. Guardabassi L, Houser GA, Frank LA, Papich MG. Guidelines for antimicrobial use in dogs and cats. In: Guardabassi L, Jensen LB, Kruse H, editors. Guide to antimicrobial use in animals. Ames (IA): Blackwell; 2008. p. 183-206.
18. Pedersen K, Pedersen K, Jensen H, Finster K, Jensen VF, Heuer OE. Occurrence of antimicrobial resistance in bacteria from diagnostic samples from dogs. J Antimicrob Chemother. 2007;60:775-81. DOI: 10.1093/jac/dkm269
19. Walker RD. Fluoroquinolones. In: Prescott JF, Baggot JD, Walker RD, editors. Antimicrobial therapy in veterinary medicine. 3rd ed. Ames (IA): Iowa State University Press; 2000. p. 315-38.
20. Chaves F, Garcia-Martinez J, de Miguel S, Sanz F, Otero JR. Epidemiology and clonality of methicillin-resistant and methicillin-susceptible Staphylococcus aureus causing bacteremia in a tertiary-care hospital in Spain. Infect Control Hosp Epidemiol. 2005;26:150-6. DOI: 10.1086/502519
21. Weber SG, Gold HS, Hooper DC, Karchmer AW, Carmeli Y. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis. 2003;9:1415-22.
22. Aldeyab MA, Monnet DL, Lopez-Lozano JM, Hughes CM, Scott MG, Kearney MP, et al. Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis. J Antimicrob Chemother. 2008;62:593-600. DOI: 10.1093/jac/dkn198
23. Bisognano C, Vaudaux P, Rohner P, Lew DP, Hooper DC. Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin. Antimicrob Agents Chemother. 2000;44:1428-37. DOI: 10.1128/AAC.44.6.1428-1437. 2000
24. Muller A, Mauny F, Talon D, Donnan PT, Harbarth S, Bertrand X. Effect of individual-and group-level antibiotic exposure on MRSA isolation: a multilevel analysis. J Antimicrob Chemother. 2006;58:878-81. DOI: 10.1093/jac/dkl343
25. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis. 2003;36:131-9. DOI: 10.1086/345436
26. Coello R, Glynn JR, Gaspar C, Picazo JJ, Fereres J. Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA. J Hosp Infect. 1997;37:39-46. DOI: 10.1016/S0195-6701(97)90071-2
27. Anderson MEC, Lefebvre SL, Rankin SC, Aceto H, Morley PS, Caron JP, et al. Retrospective multicentre study of methicillin-resistant Staphylococcus aureus infections in 115 horses. Equine Vet J. 2009;41:401-5. DOI: 10.2746/042516408X345134